IRIDEX to Present at the 2020 Stifel Virtual Healthcare Conference

Rhea-AI Summary

IRIDEX Corporation (Nasdaq: IRIX) announced its participation in the Stifel Virtual Healthcare Conference on November 17, 2020, at 4:40 pm ET. David I. Bruce, the CEO, will present, and interested individuals can access the live and archived webcast via the IRIDEX website.

IRIDEX specializes in laser-based medical systems for ophthalmology, notably using MicroPulse technology for treating conditions like glaucoma and diabetic macular edema. Its products are available in over 100 countries.

MOUNTAIN VIEW, Calif., Nov. 03, 2020 (GLOBE NEWSWIRE) -- IRIDEX Corporation (Nasdaq: IRIX) today announced the Company plans to participate in the upcoming Stifel Virtual Healthcare Conference.

David I. Bruce, IRIDEX’s President and Chief Executive Officer, is scheduled to present on Tuesday, November 17, 2020, at 4:40 pm ET. Interested parties may access a live and archived webcast of the presentation at http://www.iridex.com.

About IRIDEX
IRIDEX Corporation is a worldwide leader in developing, manufacturing, and marketing innovative and versatile laser-based medical systems, delivery devices and consumable instrumentation for the ophthalmology market. IRIDEX’s proprietary MicroPulse^® technology delivers a differentiated treatment that provides safe, effective, and proven treatment for targeted sight-threatening eye conditions. IRIDEX’s current product line is used for the treatment of glaucoma and diabetic macular edema (DME) and other retinal diseases. IRIDEX products are sold in the United States through a direct sales force and internationally primarily through a network of independent distributors into more than 100 countries. For further information, visit the IRIDEX website at www.iridex.com.

Investor Relations Contact
Leigh Salvo
(415) 937-5404
investors@iridex.com

FAQ

When is IRIDEX presenting at the Stifel Virtual Healthcare Conference?

IRIDEX will present on November 17, 2020, at 4:40 pm ET.

Who will represent IRIDEX at the conference?

David I. Bruce, the President and CEO of IRIDEX, will represent the company.

How can I access the IRIDEX presentation?

The presentation can be accessed via a live and archived webcast on the IRIDEX website.

What technology does IRIDEX use for its medical products?

IRIDEX uses MicroPulse technology for its laser-based ophthalmic treatments.

What conditions do IRIDEX products treat?

IRIDEX products treat glaucoma, diabetic macular edema, and other retinal diseases.

In how many countries are IRIDEX products sold?

IRIDEX products are sold in over 100 countries worldwide.